Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

doi 10.4016/32810.01
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SciVee, Inc

Related search

Locoregional and Systemic Therapy for Hepatocellular Carcinoma

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

MRI Assessment of Hepatocellular Carcinoma After Locoregional Therapy

Insights into Imaging
Nuclear MedicineRadiologyImaging
2019English

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Encouraging but Insufficient

HepatoBiliary Surgery and Nutrition
2018English

Factors Associated With Radiographic Response and Overall Survival After Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma With Portal Vein Thrombosis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-Based Review

Journal of Clinical and Translational Hepatology
2018English

Neutrophil-To-Lymphocyte Ratio Predicts Survival in European Patients With Hepatocellular Carcinoma Administered Sorafenib

Oncotarget
Oncology
2017English

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy